Drug search by name

Safinamide Mesylate and Hepatic impairment

Result of checking the interaction of drug Safinamide Mesylate and disease Hepatic impairment for safety when used together.

Check result:

Safinamide Mesylate <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Safinamide is contraindicated in patients with severe hepatic dysfunction (Child-Pugh C). In patients with moderate hepatic impairment the maximum recommended dose is 50 mg orally once a day. If a patient taking this dose progresses from moderate to severe hepatic impairment, safinamide should be discontinued.

Safinamide Mesylate

Generic Name: safinamide

Brand Name: Xadago

Synonyms: Safinamide

What is Safinamide Mesylate?